McKesson Corp (NYSE:MCK)

CAPS Rating: 5 out of 5

Providing supply, information and care management products and services designed to reduce costs and improve quality across the healthcare industry.


Player Avatar brenoboyle (< 20) Submitted: 1/19/2013 12:05:52 PM : Outperform Start Price: $103.67 MCK Score: +0.75

Increasing coverage for prescription drug benefits, very shareholder friendly consistant repurchases, patent cliff for pharma will led to more generic prescription drug coverage for which MCK has higher margins.

Featured Broker Partners